← Leaderboards
Howard Levin
Coridea, Llc
$9,660,641
Attributed
$12,376,637
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,376,637 · 9
By mechanism
R44$7,976,757 · 4
UH3$2,694,009 · 1
UG3$927,319 · 1
R43$778,552 · 3
Top collaborators
- Sandra D. Comer3 shared
- Alonso Guedes3 shared
- Gebhard Wagener3 shared
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignDevicesSmall Business Innovation Research GrantPrototypeGrantSafetyMedicalLifeFutureClinical TrialsMinimally InvasiveAnimalsVerification And ValidationMeetingsAcuteSafety TestingPre-Clinical ModelChronicAnimal ModelBaseFamily SuidaeResponseMortalityPreparation
Grant awards (18)
Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose$2,544,126
UH3 · FY2025 · DA · contact PI
Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose$149,883
UH3 · FY2025 · DA · contact PI
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy$941,991
R44 · FY2024 · HL · contact PI
Stellate Ganglion Stimulation in Septic Shock to Improve Hemodynamics and Vasopressor Requirements$274,839
R43 · FY2024 · GM · contact PI
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy$122,700
R44 · FY2024 · HL · contact PI
Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose$927,319
UG3 · FY2023 · DA · contact PI
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy$784,548
R44 · FY2023 · HL · contact PI
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy$122,700
R44 · FY2023 · HL · contact PI
Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation$784,016
R44 · FY2022 · CA · contact PI
Coridea NIH I-Corps Program$54,863
R43 · FY2022 · DA · contact PI
Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation$783,896
R44 · FY2021 · CA · contact PI
On Demand Electrostimulation$223,921
R43 · FY2021 · DA · contact PI
Painless Defibrillation$982,600
R44 · FY2020 · HL · contact PI
Painless Defibrillation$993,536
R44 · FY2019 · HL · contact PI
Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation$224,929
R43 · FY2019 · CA · contact PI
Painless Defibrillation$994,306
R44 · FY2018 · HL · contact PI
Prevention of Syncope with GSN Stimulation$726,029
R44 · FY2017 · HL · contact PI
Prevention of Syncope with GSN Stimulation$740,435
R44 · FY2016 · HL · contact PI